SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-302256
Filing Date
2022-12-12
Accepted
2022-12-12 07:32:39
Documents
17
Period of Report
2022-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d346985d8k.htm   iXBRL 8-K 68484
2 EX-2.1 d346985dex21.htm EX-2.1 540727
3 EX-2.2 d346985dex22.htm EX-2.2 26156
4 EX-10.1 d346985dex101.htm EX-10.1 772398
5 EX-99.1 d346985dex991.htm EX-99.1 304859
  Complete submission text file 0001193125-22-302256.txt   2242791

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA amgn-20221211.xsd EX-101.SCH 3872
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20221211_def.xml EX-101.DEF 13252
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20221211_lab.xml EX-101.LAB 21840
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20221211_pre.xml EX-101.PRE 14155
11 EXTRACTED XBRL INSTANCE DOCUMENT d346985d8k_htm.xml XML 5143
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 221456150
SIC: 2836 Biological Products, (No Diagnostic Substances)